Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Accumulated Expenses: 2019-2022

  • ADC Therapeutics' Other Accumulated Expenses rose 17.56% to $14,963 in Q4 2022 from the same period last year, while for Dec 2022 it was $14,963, marking a year-over-year increase of 17.56%. This contributed to the annual value of $14,963 for FY2022, which is 17.56% up from last year.
  • As of Q4 2022, ADC Therapeutics' Other Accumulated Expenses stood at $14,963, which was up 17.56% from $12,728 recorded in Q4 2021.
  • ADC Therapeutics' Other Accumulated Expenses' 5-year high stood at $14,963 during Q4 2022, with a 5-year trough of -$7.0 million in Q4 2019.
  • Its 2-year average for Other Accumulated Expenses is $13,846, with a median of $13,846 in 2021.
  • Data for ADC Therapeutics' Other Accumulated Expenses shows a peak YoY climbed of 17.56% (in 2022) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Other Accumulated Expenses (Quarterly) stood at -$7.0 million in 2019, then reached $12,728 in 2021, then increased by 17.56% to $14,963 in 2022.
  • Its Other Accumulated Expenses was $14,963 in Q4 2022, compared to $12,728 in Q4 2021 and -$7.0 million in Q4 2019.